Contemporary treatment and outcome of sinonasal undifferentiated carcinoma: A meta-analysis.
chemotherapy
induction chemotherapy
sinonasal cancer
sinonasal undifferentiated carcinoma (SNUC)
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
20 Aug 2024
20 Aug 2024
Historique:
revised:
25
06
2024
received:
01
10
2023
accepted:
29
07
2024
medline:
20
8
2024
pubmed:
20
8
2024
entrez:
20
8
2024
Statut:
aheadofprint
Résumé
Induction chemotherapy (IC) recently gained importance for treatment of sinonasal undifferentiated carcinoma (SNUC). We analyzed our SNUC cases and performed a meta-analysis with focus on survival-rates stratified by treatment. SNUC cases at our institution were retrospectively evaluated. A systematic literature review was conducted to analyze treatment and outcome of SNUC. To calculate 5-year and 2-year overall survival (OS), individual patient data (IPD) were analyzed using Kaplan-Meier estimators and Cox proportional hazard regression to identify associations between types of therapy and survival. A random effects model for pooled estimates of 5-year survival was applied to studies without IPD data. Five-year OS of our SNUC cases (n = 9) was 44.4%. The IPD analysis (n = 192) showed a significantly better 5-year OS for patients who received induction chemotherapy (72.6% vs. 44.5%). The pooled 5-year OS of 13 studies identified in the literature search was 43.8%. IC should be considered in every patient diagnosed with SNUC.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Bavarian Cancer Research Center (BZKF)
Informations de copyright
© 2024 The Author(s). Head & Neck published by Wiley Periodicals LLC.
Références
Frierson HF Jr, Mills SE, Fechner RE, Taxy JB, Levine PA. Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. Am J Surg Pathol. 1986;10(11):771‐779.
Agaimy A, Franchi A, Lund VJ, et al. Sinonasal undifferentiated carcinoma (SNUC): from an entity to morphologic pattern and back again—a historical perspective. Adv Anat Pathol. 2020;27(2):51‐60.
Tyler MA, Holmes B, Patel ZM. Oncologic management of sinonasal undifferentiated carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2019;27(1):59‐66.
Musy PY, Reibel JF, Levine PA. Sinonasal undifferentiated carcinoma: the search for a better outcome. Laryngoscope. 2002;112(8):1450‐1455.
Mendenhall WM, Mendenhall CM, Riggs CE Jr, Villaret DB, Mendenhall NP. Sinonasal undifferentiated carcinoma. Am J Clin Oncol. 2006;29(1):27‐31.
Lopez F, Suárez V, Vivanco B, Suárez C, Llorente JL. Current management of sinonasal undifferentiated carcinoma. Rhinology. 2015;53(3):212‐220.
Al‐Mamgani A, van Rooij P, Mehilal R, Tans L, Levendag PC. Combined‐modality treatment improved outcome in sinonasal undifferentiated carcinoma: single‐institutional experience of 21 patients and review of the literature. Eur Arch Otorhinolaryngol. 2013;270(1):293‐299.
Chambers KJ, Lehmann AE, Remenschneider A, et al. Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States. J Neurol Surg B Skull Base. 2015;76(2):94‐100.
Kuan EC, Arshi A, Mallen‐St Clair J, Tajudeen BA, Abemayor E, St John MA. Significance of tumor stage in sinonasal undifferentiated carcinoma survival: a population‐based analysis. Otolaryngol Head Neck Surg. 2016;154(4):667‐673.
Amit M, Abdelmeguid AS, Watcherporn T, et al. Induction chemotherapy response as a guide for treatment optimization in sinonasal undifferentiated carcinoma. J Clin Oncol. 2019;37(6):504‐512.
London NR Jr, Mohyeldin A, Daoud G, et al. Sinonasal undifferentiated carcinoma: institutional trend toward induction chemotherapy followed by definitive chemoradiation. Head Neck. 2020;42(11):3197‐3205.
de Bonnecaze G, Verillaud B, Chaltiel L, et al. Clinical characteristics and prognostic factors of sinonasal undifferentiated carcinoma: a multicenter study. Int Forum Allergy Rhinol. 2018;8(9):1065‐1072.
Lehrich BM, Goshtasbi K, Abiri A, et al. Impact of induction chemotherapy and socioeconomics on sinonasal undifferentiated carcinoma survival. Int Forum Allergy Rhinol. 2020;10(5):679‐688.
Thompson LDR, Bishop JA. Update from the 5th edition of the World Health Organization classification of head and neck tumors: nasal cavity, paranasal sinuses and skull base. Head Neck Pathol. 2022;16(1):1‐18.
Riobello C, López‐Hernández A, Cabal VN, et al. IDH2 mutation analysis in undifferentiated and poorly differentiated sinonasal carcinomas for diagnosis and clinical management. Am J Surg Pathol. 2020;44(3):396‐405.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. Int J Surg (London, England). 2010;8(5):336‐341.
Tanzler ED, Morris CG, Orlando CA, Werning JW, Mendenhall WM. Management of sinonasal undifferentiated carcinoma. Head Neck. 2008;30(5):595‐599.
Abdelmeguid AS, Bell D, Hanna EY. Sinonasal undifferentiated carcinoma. Curr Oncol Rep. 2019;21(3):26.
Devisetty K, Wong SJ. Neoadjuvant versus induction chemotherapy: more than semantics. J Clin Oncol. 2013;31(23):2971‐2972.
Christopherson K, Werning JW, Malyapa RS, Morris CG, Mendenhall WM. Radiotherapy for sinonasal undifferentiated carcinoma. Am J Otolaryngol. 2014;35(2):141‐146.
Kim SA, Chung YS, Lee BJ. Recurrence patterns of sinonasal cancers after a 5‐year disease‐free period. Laryngoscope. 2019;129(11):2451‐2457.
Chen AM, Daly ME, El‐Sayed I, et al. Patterns of failure after combined‐modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2008;70(2):338‐343.
Gamez ME, Lal D, Halyard MY, et al. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): the Mayo Clinic experience. Head Neck. 2017;39(9):1819‐1824.
Workman AD, Brody RM, Kuan EC, et al. Sinonasal undifferentiated carcinoma: a 15‐year single institution experience. J Neurol Surg B Skull Base. 2019;80(1):88‐95.
Khan MN, Konuthula N, Parasher A, et al. Treatment modalities in sinonasal undifferentiated carcinoma: an analysis from the national cancer database. Int Forum Allergy Rhinol. 2017;7(2):205‐210.
Orlandi E, Cavalieri S, Granata R, et al. Locally advanced epithelial sinonasal tumors: the impact of multimodal approach. Laryngoscope. 2020;130(4):857‐865.
Kong KA, Thorp BD, Sheth SH. The role of induction therapy for sinonasal cancers. Curr Treat Options Oncol. 2023;24(3):162‐169.
Ock CY, Keam B, Kim TM, et al. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation. Korean J Intern Med. 2016;31(3):570‐578.
Rischin D, Porceddu S, Peters L, Martin J, Corry J, Weih L. Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma. Head Neck. 2004;26(5):435‐441.
Ove R, Nabell LM. Induction chemotherapy for head and neck cancer: is there still a role? Future Oncol. 2016;12(13):1595‐1608.
Wolf GT, Fisher SG, Hong WK, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324(24):1685‐1690.
Takahashi Y, Gleber‐Netto FO, Bell D, et al. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Oral Oncol. 2019;97:56‐61.
Reiersen DA, Pahilan ME, Devaiah AK. Meta‐analysis of treatment outcomes for sinonasal undifferentiated carcinoma. Otolaryngol Head Neck Surg. 2012;147(1):7‐14.
Morand GB, Anderegg N, Vital D, et al. Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): a case‐series, systematic review and meta‐analysis. Oral Oncol. 2017;75:28‐34.
Mallur P, Ikeda A, Patel A, et al. Evidence‐based medicine in otolaryngology part 14: falsehood and bias. Otolaryngol Head Neck Surg. 2023;168(6):1584‐1595.